newsfilter
← Latest News
ACCESS Newswire·

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

SHELTON, CT / ACCESS Newswire / September 23, 2026 / NanoViricides, Inc. today announced that the Phase II Clinical Trial of the Company's Novel Broad-Spectrum Antiviral Drug